CyberKnife (a type of stereotactic radiosurgery, SRS) is a non-invasive, robotic radiation therapy system that delivers highly precise, targeted radiation to tumors or lesions—without the need for surgery. It is commonly used for brain tumors, spinal lesions, prostate cancer, lung cancer, and other malignancies.
Key Features:
No incision – Non-surgical alternative to traditional surgery. Extreme precision – Uses real-time imaging & AI-guided robotics to adjust for patient movement. Fewer sessions – Typically 1-5 treatments (vs. weeks of conventional radiation). Minimal side effects – Less damage to surrounding healthy tissue.
Indications of CyberKnife Therapy
Brain Tumours
- Difficulty with speech and vision, headaches, convulsions, and balance.
Thyroid tumours:
- Weakness, numbness, paralysis, and back pain.
The cancer of the prostate:
- Urine problems and, if severe, pelvic pain.
Lung cancer is:
- Breathlessness, chest pain, and a persistent cough.
What is a Candidate?
- Individuals having tumours of small to medium size.
- People unable to have surgery (because of health risks).
- Situations where traditional radiation was ineffective.
